Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP
NCT06015074 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136
Last updated 2024-05-31
Summary
Intravenous anesthesia has been widely used in endoscopic retrograde cholangiopancreatography (ERCP). In the past decade, many practices have been carried out under the propofol-based monitored anesthesia care without endotracheal intubation in patients undergoing ERCP.
Ciprofol is a newly developed intravenous anesthetic with a potency 4-5 times than that of propofol. Ciprofol seems a promising anesthetic agent for intravenous anesthesia but the evidence supported its application in ERCP is still limited.
Conditions
- Anesthesia; Adverse Effect
- Biliary Tract Diseases
Interventions
- DRUG
-
Propofol
patients in Propofol group receive sufentanil(0.1ug/kg)+ propofol (1.5-2mg/kg) for anesthesia induction, and continuous infusion of propofol 5mg/kg/h for anesthesia maintain.
- DRUG
-
Ciprofol
patients in Ciprofol group receive sufentanil(0.1ug/kg)+ ciprofol(0.4-0.5mg/kg) for anesthesia induction, and continuous infusion of ciprofol 0.8mg/kg/h for anesthesia maintain.
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Principal Investigators
-
Peiying Li, Doctor · Clinial Research Center, Renji Hospital
-
Yu Weifeng, Doctor · Department of Anesthesiology, Renji Hospital
-
Zheng Li, Master · Department of Anesthesiology, Renji Hospital
-
Yanhua Zhao, Doctor · Department of Anesthesiology, Renji Hospital
-
Yifeng Qu, Master · Department of Anesthesiology, Renji Hospital
-
Kun Luo, Master · Department of Anesthesiology, Renji Hospital
-
Guangyan Wang · Operating Room,Renji Hospital
-
Teng Wang · Department of Anesthesiology, Renji Hospital
-
Huichen Zhu, Master · Department of Anesthesiology, Renji Hospital
-
Jing Gao, Doctor · Clinial Research Center, Renji Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-15
- Primary Completion
- 2024-12-31
- Completion
- 2025-02-28
Countries
- China
Study Locations
Related Clinical Trials
-
Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01540084 · Status: COMPLETED · Phase: PHASE4
- Disorders of Gallbladder, Biliary Tract and Pancreas
-
Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography
NCT01505218 · Status: COMPLETED · Phase: NA
- Endoscopic Retrograde Cholangiopancreatography
-
Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
NCT04860167 · Status: COMPLETED · Phase: NA
- Biliary Colic
-
Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis
NCT04997967 · Status: UNKNOWN · Phase: PHASE4
- Conscious Sedation Failure During Procedure
-
Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01321047 · Status: UNKNOWN · Phase: PHASE4
- Conscious Sedation Failure During Procedure
More Related Trials
-
Randomized Controlled Study for Analyzing Clinical Benefit of Pain Focused Sedation With Combination of Fentanyl and Propofol During Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01840371 ·Status: COMPLETED ·Phase: NA
-
Target-controlled Infusion Versus Patient-controlled Sedation With Propofol in Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01072435 ·Status: COMPLETED ·Phase: PHASE4
-
RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP
NCT02046590 ·Status: TERMINATED ·Phase: NA
-
Comparison of Different Ratio of Ketofol (6:1 vs. 4:1) for Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT04029831 ·Status: COMPLETED ·Phase: NA
-
Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01079312 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.
NCT01709422 ·Status: COMPLETED ·Phase: PHASE4
-
Doxapram as an Additive to Propofol Sedation in Sedation for ERCP
NCT02171910 ·Status: COMPLETED ·Phase: PHASE4
-
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
NCT07012772 ·Status: RECRUITING ·Phase: PHASE2
-
Ketamine- Propofol Versus Pethidine- Propofol in ERCP
NCT02651792 ·Status: COMPLETED ·Phase: PHASE2
-
Etomidate vs. Midazolam for Sedation During ERCP
NCT02027311 ·Status: COMPLETED ·Phase: PHASE4
-
CO2 Versus O2 Insufflation During ERCP Depending on Sedation Protocols
NCT01761474 ·Status: COMPLETED
-
Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01350037 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Positioning and Airway Management During ERCP
NCT02850887 ·Status: COMPLETED ·Phase: NA
-
Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01143766 ·Status: COMPLETED ·Phase: NA
-
Effect of Lidocaine Aerosol Plus Low-dose Cisatracurium vs Conventional-dose Cisatracurium on Intubation Conditions in ERCP - A Randomized Trial
NCT07185074 ·Status: RECRUITING ·Phase: PHASE4
-
Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?
NCT00675415 ·Status: COMPLETED ·Phase: NA
-
Intravenous Infusion of Lidocaine in ERCP
NCT03996577 ·Status: UNKNOWN ·Phase: PHASE4
-
EEG-Guided Sedation in ERCP Procedures
NCT06866886 ·Status: COMPLETED
-
High Flow Nasal Oxygen Versus Standard Nasal Oxygen in Endoscopic Retrograde Cholangiopancreatography Under Sedation
NCT06689033 ·Status: COMPLETED
-
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
NCT06111872 ·Status: COMPLETED ·Phase: PHASE2
-
Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01321203 ·Status: COMPLETED
-
Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy
NCT03388151 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevention of Desaturations Using Positive Airway Pressure or Capnometry During ERCP
NCT07056075 ·Status: RECRUITING ·Phase: NA
-
IV Fluids and Post-ERCP Pancreatitis
NCT05211206 ·Status: RECRUITING
-
Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation
NCT01070680 ·Status: COMPLETED ·Phase: PHASE4